Home Bancshares, Inc.
NYSE:HOMBBanks - Regional
+$0.41 today
- Market cap
- $5.80B
- Beta
- 0.69
- P/E (TTM)
- 11.5
- EPS (TTM)
- $2.43
- Dividend yield
- 2.98%
Volume 1.18M
Average 1.52M
HOMB Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Home Bancshares, Inc.NYSE: HOMB
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How HOMB compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for HOMB, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | COP 0 COP | — | — | 0.0% | |
| Peer median (excluding HOMB) | — | — | — | 0.0% | |
Competitors are the stored peer set for HOMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 751.98M | 1.04B | 1.33B | 1.45B | 1.37B |
| Cost of Revenue | 47.45M | 180.67M | 358.56M | 499.4M | 312M |
| Gross Profit | 704.54M | 855.3M | 967.81M | 952.6M | 1.06B |
| Gross Margin | 93.7% | 82.6% | 73.0% | 65.6% | 77.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 185.81M | 260.48M | 296.73M | 268.78M | 340.76M |
| Operating Expenses | 287.76M | 460.73M | 455.93M | 430.26M | 461.06M |
| Depreciation & Amortization | 19.48M | 31.86M | 30.93M | 29.2M | 29.19M |
| EBITDA | 436.26M | 426.43M | 542.81M | 551.54M | 630.5M |
| EBITDA Margin | 58.0% | 41.2% | 40.9% | 38.0% | 45.9% |
| Operating Income | 416.78M | 394.58M | 511.88M | 522.34M | 601.31M |
| Operating Margin | 55.4% | 38.1% | 38.6% | 36.0% | 43.8% |
| Interest Income | 625.17M | 877.77M | 1.18B | 1.3B | 1.28B |
| Interest Expense | 52.2M | 119.09M | 348.11M | 451M | 408.78M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 416.78M | 394.58M | 511.88M | 522.34M | 601.31M |
| Pre-Tax Margin | 55.4% | 38.1% | 38.6% | 36.0% | 43.8% |
| Income Tax Expense | 97.75M | 89.31M | 118.95M | 120.1M | 125.86M |
| Net Income | 319.02M | 305.26M | 392.93M | 402.24M | 475.44M |
| Net Margin | 42.4% | 29.5% | 29.6% | 27.7% | 34.6% |
| EPS (Basic) | 1.94 | 1.57 | 1.94 | 2.01 | 2.41 |
| EPS (Diluted) | 1.94 | 1.57 | 1.94 | 2.01 | 2.41 |
| Weighted Avg Shares | 164.5M | 194.69M | 202.63M | 199.94M | 197.04M |
| Weighted Avg Shares (Diluted) | 164.86M | 195.02M | 202.77M | 200.07M | 197.65M |
Home Bancshares, Inc.
NYSE:HOMB
Intrinsic Alpha fair value
Locked
Current Price
$29.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.